Please assess the completion status of the following clinical trial:

Trial Title: Endoscopic Gastric Reduction for Weight Management

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Body Mass Index (BMI) between 30 and 40~* Age \>18 and ≤50~* Stable weight for 3 months (within 5% of BMI)~* Normal basic labs (CBC, chemistry profile, creatinine)~* Negative pregnancy test for females \>18 or ≤ 50~Exclusion Criteria:~* Diabetes~* Unstable coronary artery disease~* Heart failure~* Cardiac arrhythmia~* Cardiac valvular disease~* Obstructive of interstitial lung disease~* Females of child-bearing age \>18 or ≤ 50 who are pregnant or lactating~* Mallampati score of 4~* ASA 3 or above~* Previous gastric surgery~* Ulcer disease~* Gastroparesis,~* \> 5 cm Hiatal hernia~* Congenital anomalies of the GI tract~* Currently on or prescribed a medication known to affect weight within 3 months of study entry.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Botulinum toxin at injection site (Type: EXPERIMENTAL): All subjects will have gastroplasty performed using the Overstitch Endoscopic Suturing System. Botulinum toxin will be injected in every other suture site in half of the randomly patients selected.

Based on this trial design, predict the completion outcome and termination type (if applicable).